Science Daily·3 min read·medium

Lab-grown mini brains may predict which Alzheimer’s treatments will work

Lab-grown mini brains may predict which Alzheimer’s treatments will work
AI Summary

Johns Hopkins researchers are using patient-derived brain organoids to predict how individuals with Alzheimer's disease respond to psychiatric medications. The study also identified extracellular vesicles as potential biomarkers for disease progression.

Scientists at Johns Hopkins Medicine have found new evidence that small clusters of brain tissue grown from the cells of people with Alzheimer's disease could help researchers predict how different patients may respond to medications used to manage psychiatric symptoms linked to the condition.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in